In particular, the concomitant overexpression of N-cadherin and CD133 was revealed in both circulating tumor cells [44, 45] and breast cancer specimens [46], even if a significant correlation between the two molecules and patient's prognosis was not fully demonstrated. Here, PROM1 is linked to neoplasm.